Zai Lab Announces Upcoming Presentations at September Conferences Read more about Zai Lab Announces Upcoming Presentations at September Conferences
Zai Lab to Report Financial Results for the Six Months Ended June 30, 2019 and Provide Corporate Update on September 3, 2019 Read more about Zai Lab to Report Financial Results for the Six Months Ended June 30, 2019 and Provide Corporate Update on September 3, 2019
China National Medical Products Administration Grants Innovative Medical Device Designation for Optune® in China Read more about China National Medical Products Administration Grants Innovative Medical Device Designation for Optune® in China
Incyte and Zai Lab Announce Collaboration and License Agreement for INCMGA0012 in Greater China Read more about Incyte and Zai Lab Announce Collaboration and License Agreement for INCMGA0012 in Greater China
Zai Lab Announces Approval to Commercialize ZEJULA (Niraparib) in Macau for Patients with Relapsed Ovarian Cancer Read more about Zai Lab Announces Approval to Commercialize ZEJULA (Niraparib) in Macau for Patients with Relapsed Ovarian Cancer
Deciphera Pharmaceuticals, Inc. and Zai Lab Limited Announce an Exclusive License Agreement for Ripretinib in Greater China Read more about Deciphera Pharmaceuticals, Inc. and Zai Lab Limited Announce an Exclusive License Agreement for Ripretinib in Greater China
Abstracts and posters on Tumor Treating Fields presenting in ASCO 2019 Read more about Abstracts and posters on Tumor Treating Fields presenting in ASCO 2019
TESARO presented new data from niraparib programs at ASCO 2019 Read more about TESARO presented new data from niraparib programs at ASCO 2019
Zai Lab Appoints Valeria Fantin, Ph.D., as Chief Scientific Officer Read more about Zai Lab Appoints Valeria Fantin, Ph.D., as Chief Scientific Officer
Dr. Samantha Du named in the Forbes’ first list of China’s Top 50 Women in Tech Read more about Dr. Samantha Du named in the Forbes’ first list of China’s Top 50 Women in Tech